A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 19, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q3 FY2026, filed Nov 6, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the BCBP SEC filings page.
BCB Bancorp Inc (BCBP) reported $101.8M in revenue over the twelve months to Sep 30, 2026, up 3.2% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
BCB's 2025 numbers show a shrinking, liability-funded bank where positive cash generation coexisted with an accounting loss.
The key mismatch is that BCB reported a net loss of$12.5M but still produced operating cash flow of$35.9M ; the loss therefore did not represent a matching cash outflow. That cash generation weakened from FY2024 even as interest expense fell21.6% , indicating lower funding cost alone did not restore reported profitability.
This is a balance-sheet business, not an asset-light one: liabilities were
Free cash flow remained close to operating cash flow in FY2025, with capital expenditures at only
Financial Health Signals
Scored against banks for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed: here 5 of 6, with the others left out rather than counted as zero. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of BCB Bancorp Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Earnings ranks banks on their return on assets, the profit made on every dollar of assets on the books, averaged over the last three fiscal years with the newest weighted most. BCB Bancorp Inc scores 10/100 on it among other banks.
Growth ranks banks on the yearly rate at which their net revenue, which is interest income and fee income less the interest they pay out, compounded across the last three fiscal years (the last two where the earliest reports none), counted in the currency each bank reports in. BCB Bancorp Inc scores 8/100 on it among other banks.
BCB Bancorp Inc funded 9.3% of its assets with shareholders' equity at the end of fiscal year 2025, holding $304.3M of equity against $3.3B of assets. Capital ranks banks on that cushion, and BCB Bancorp Inc scores 26/100 among other banks.
Efficiency measures what a bank spends running itself against the revenue that spending brings in, so a lower ratio is the better one. BCB Bancorp Inc scores 37/100 on it among other banks.
Not available for BCB Bancorp Inc, so it is left out of the overall score, which averages the 5 of 6 dimensions that can be computed.
Stability ranks banks on how far their net income strayed from its own average over the last five fiscal years, measured against the size of that average, and a smaller spread ranks higher. BCB Bancorp Inc scores 17/100 on it among other banks.
BCB Bancorp Inc passes 3 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), the one computable operating efficiency signal (asset turnover improving) passes.
Key Financial Metrics
Earnings & Revenue
BCB Bancorp Inc generated $27.8M in revenue in Q3 2026. This represents an increase of 5.0% from the same quarter a year earlier. Against the prior quarter it is up 21.4%.
BCB Bancorp Inc reported a net loss of $132.5M in Q3 2026. This represents a decrease of 3207.8% from the same quarter a year earlier. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
BCB Bancorp Inc earned -$6.92 per diluted share (EPS) in Q3 2026. This represents a decrease of 3245.5% from the same quarter a year earlier. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Not reported for Q3 2026.
Cash & Balance Sheet
BCB Bancorp Inc generated $4.7M in free cash flow in Q3 2026, representing cash available after capex. This represents a decrease of 44.0% from the same quarter a year earlier. Against the prior quarter it is down 49.3%.
BCB Bancorp Inc held $500.3M in cash as of Q3 2026; no long-term debt figure is on record for that period.
Not reported for Q3 2026.
Margins & Returns
BCB Bancorp Inc's quarterly ROE was -53.8% in Q3 2026: one quarter's net income over shareholder equity, not annualized. This is down 55.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 48.8 percentage points.
Not reported for Q3 2026.
Not reported for Q3 2026.
Not shown for Q3 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Capital Allocation
BCB Bancorp Inc invested $257K in capex in Q3 2026, funding long-term assets and infrastructure. This represents a decrease of 8.2% from the same quarter a year earlier. Against the prior quarter it is up 8.4%.
Not reported for Q3 2026.
Not reported for Q3 2026.
BCBP Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Revenue | $27.8M+5.0% | $22.9M-9.1% | $24.9M+4.8% | $26.2M+13.1% | $26.5M+1.1% | $25.2M+23.4% | $23.8M-5.8% | $23.1M-14.8% |
| Interest Expense | $15.8M-18.4% | $17.1M-14.8% | $17.6M-20.8% | $18.3M-25.1% | $19.3M-24.4% | $20.1M-22.2% | $22.2M-15.1% | $24.5M-5.1% |
| Income Tax | $23.5M+1419.7% | -$3.5M-338.4% | $1.7Mn/m | -$5.4M-502.2% | $1.5M-42.5% | $1.5M+25.1% | -$3.4M-237.6% | $1.3M-48.4% |
| Net Income | -$132.5M-3207.8% | -$14.8M-514.6% | $4.9Mn/m | -$12.0M-467.6% | $4.3M-36.1% | $3.6M+26.5% | -$8.3M-241.9% | $3.3M-46.0% |
| EPS (Basic) | -$6.92-3245.5% | -$0.85-572.2% | $0.26n/m | -$0.73-529.4% | $0.22-38.9% | $0.18+28.6% | -$0.51-259.4% | $0.17-51.4% |
| EPS (Diluted) | -$6.92-3245.5% | -$0.85-572.2% | $0.26n/m | -$0.73-529.4% | $0.22-38.9% | $0.18+28.6% | -$0.51-259.4% | $0.17-51.4% |
| Diluted Shares (Avg) | 19M+11.2% | 17M+0.8% | 17M+1.2% | N/A | 17M+0.8% | 17M+1.0% | 17M+1.0% | N/A |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA.
BCBP Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $3.0B-9.9% | $3.1B-7.8% | $3.3B-5.9% | $3.3B-8.9% | $3.4B-7.2% | $3.4B-10.9% | $3.5B-9.8% | $3.6B-6.1% |
| Cash & Equivalents | $500.3M+100.4% | $196.9M-4.8% | $293.7M+16.2% | $276.6M-12.8% | $249.6M+2.7% | $206.9M-36.7% | $252.8M-28.3% | $317.3M+13.5% |
| Goodwill | $0 | $0 | $5.2M | $5.3M | N/A | N/A | N/A | N/A |
| Total Liabilities | $2.8B-8.6% | $2.8B-7.8% | $3.0B-6.2% | $3.0B-9.2% | $3.0B-7.6% | $3.1B-11.8% | $3.2B-10.5% | $3.3B-6.9% |
| Total Equity | $246.1M-22.7% | $291.9M-7.5% | $307.4M-2.3% | $304.3M-6.1% | $318.5M-2.9% | $315.7M-1.6% | $314.7M-1.7% | $323.9M+3.1% |
| Retained Earnings | -$29.2M-122.2% | $103.2M-21.0% | $119.4M-8.3% | $116.4M-17.9% | $131.7M-7.1% | $130.6M-5.6% | $130.3M-6.0% | $141.9M+4.4% |
Not reported in any period shown, so not listed: Current Assets, Short-Term Investments, Inventory, Accounts Receivable, Long-Term Investments, Current Liabilities, Non-Current Liabilities, Long-Term Debt.
BCBP Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $5.0M-42.9% | $9.6M-7.3% | $5.2M+3.3% | $11.8M+52.1% | $8.7M-79.9% | $10.3M+27.2% | $5.0M-39.6% | $7.8M+1067.3% |
| Stock-Based Compensation | N/A | N/A | $148K-53.9% | N/A | N/A | N/A | $321K+64.6% | N/A |
| Capital Expenditures | $257K-8.2% | $237K+51.9% | $266K-8.6% | $320K-66.4% | $280K+214.6% | $156K+290.0% | $291K+102.1% | $952K+395.8% |
| Free Cash Flow | $4.7M-44.0% | $9.3M-8.2% | $4.9M+4.0% | $11.5M+68.6% | $8.5M-80.5% | $10.2M+25.9% | $4.7M-42.1% | $6.8M+1338.7% |
| Investing Cash Flow | $258.9M+291.8% | $31.1M-25.3% | $24.7M-47.4% | $77.6M-7.0% | $66.1M+5.9% | $41.7M+67.0% | $47.0M-9.5% | $83.5M+442.6% |
| Financing Cash Flow | $39.5Mn/m | -$137.6Mn/m | -$12.8Mn/m | -$62.5Mn/m | -$32.1Mn/m | -$97.9Mn/m | -$116.5M-1015.5% | -$17.1M-248.0% |
| Dividends Paid | $0-100.0% | $1.4M-49.0% | $1.4M-48.6% | $2.6M+0.8% | $2.6M+0.6% | $2.7M+2.9% | $2.7M+2.7% | $2.6M+1.8% |
Not reported in any period shown, so not listed: Depreciation & Amortization, Share Buybacks.
BCBP Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Net Margin | -476.9% | -64.6%-78.8pp | 19.7%+54.6pp | -46.0%-60.1pp | 16.1%-9.4pp | 14.2%+0.4pp | -35.0%-58.2pp | 14.1%-8.2pp |
| Return on Equity | -53.8%-55.2pp | -5.1%-6.2pp | 1.6%+4.2pp | -4.0%-5.0pp | 1.3%-0.7pp | 1.1%+0.2pp | -2.6%-4.5pp | 1.0%-0.9pp |
| Return on Assets | -4.4%-4.5pp | -0.5%-0.6pp | 0.1%+0.4pp | -0.4%-0.5pp | 0.1%-0.1pp | 0.1%0.0pp | -0.2%-0.4pp | 0.1%-0.1pp |
| Liabilities-to-Equity | 11.28+1.7x | 9.680.0x | 9.64-0.4x | 9.78-0.3x | 9.53-0.5x | 9.71-1.1x | 10.04-1.0x | 10.11-1.1x |
| Asset Turnover | 0.010.0x | 0.010.0x | 0.010.0x | 0.010.0x | 0.010.0x | 0.010.0x | 0.010.0x | 0.010.0x |
| FCF Margin | 17.0%-14.9pp | 40.8%+0.4pp | 19.7%-0.1pp | 44.0%+14.5pp | 32.0% | 40.4%+0.8pp | 19.8%-12.4pp | 29.5%+27.8pp |
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio, Debt-to-Equity.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Net Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| BCB Bancorp Inc BCBP | FY2025 | $101.6M | -$12.5M | -12.3% | $278.3M | 20/100 |
| Western New England Bancorp, Inc. WNEB | FY2025 | $82.6M | $15.3M | 18.5% | $265.1M | 36/100 |
| LCNB Corporation LCNB | FY2025 | $92.0M | $23.1M | 25.1% | $272.6M | 54/100 |
| Virginia National Bankshares Corporation VABK | FY2025 | $57.6M | $19.3M | 33.4% | $292.1M | 56/100 |
| Oak Valley Bancorp OVLY | FY2025 | $81.7M | $23.9M | 29.3% | $278.3M | 51/100 |
| Hawthorn Bancshars Inc. HWBK | FY2025 | $80.2M | $23.8M | 29.7% | $285.2M | 39/100 |
Where BCB Bancorp Inc Ranks
Frequently Asked Questions
BCB Bancorp Inc (BCBP) reported $101.6M in total revenue for fiscal year 2025. This represents a 7.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
BCB Bancorp Inc (BCBP) revenue grew by 7.0% year-over-year, from $95.0M to $101.6M in fiscal year 2025.
No, BCB Bancorp Inc (BCBP) reported a net loss of $154.4M over the trailing 12 months to September 30, 2026. In fiscal year 2025 it reported a net loss of $12.5M, with a net profit margin of -12.3%.
BCB Bancorp Inc (BCBP) had a net profit margin of -12.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Yes, BCB Bancorp Inc (BCBP) paid $0.64 per share in dividends during fiscal year 2025.
BCB Bancorp Inc (BCBP) has a return on equity of -4.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
BCB Bancorp Inc (BCBP) generated $34.9M in free cash flow during fiscal year 2025. This represents a -47.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
BCB Bancorp Inc (BCBP) generated $35.9M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
BCB Bancorp Inc (BCBP) had $3.3B in total assets as of fiscal year 2025, including both current and long-term assets.
BCB Bancorp Inc (BCBP) invested $1.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
BCB Bancorp Inc (BCBP) had a liabilities-to-equity ratio of 9.78 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2025, because the filing data we hold for that year carries no long-term debt figure.
BCB Bancorp Inc (BCBP) had a return on assets of -0.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
BCB Bancorp Inc (BCBP) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to September 30, 2026). The market capitalization is $278.3M as of Nov 19, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
BCB Bancorp Inc (BCBP) trades at 2.7x sales, its market capitalization divided by $101.8M revenue, trailing 12 months to September 30, 2026. The market capitalization is $278.3M as of Nov 19, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
BCB Bancorp Inc (BCBP) has a Piotroski F-Score of 3 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
BCB Bancorp Inc (BCBP) scores 20 out of 100 on our Financial Health Score, indicating weak standing within its banks peer group. The score is the average of six dimensions (Earnings, Growth, Capital, Efficiency, Credit Quality, Stability), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. For BCB Bancorp Inc it averages the 5 of 6 dimensions that can be computed; the others are left out rather than counted as zero. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.